Transvaginal mesh has received much media attention in recent months, as reports of associated health complications increase and the Food and Drug Administration (FDA) mulls whether or not to reclassify transvaginal mesh as a high-risk medical device. The Mobile, Alabama, product liability attorneys at Long & Long are currently investigating and pursuing claims on behalf of women who suffered problems following the surgical placement of transvaginal mesh. But just what is transvaginal mesh, and what are its applications? Transvaginal mesh is a type of surgical patch designed to support the pelvic organs in the surgical repair of pelvic organ prolapse (POP) and stress urinary incontinence (SUI) in tens of thousands of women. The first transvaginal mesh device was approved by the FDA in 1996, and numerous variations made their way to market in the ensuing years through the FDA’s controversial 510(k) process, which allows a more timely approval with limited testing of new medical devices deemed equivalent to existing products. However, the number of patients who experienced transvaginal mesh failure and other complications soon began to grow to include:
- Internal bleeding
- Organ damage
- POP or SUI recurrence
- Vaginal pain
Because of the sheer number of brand names associated with transvaginal mesh devices, it’s advisable to consult with your physician if you are unsure whether transvaginal mesh was used in your surgical treatment and, if so, whether it is one of the devices associated with failure and potentially dangerous side-effects. If you suffered complications following POP or SUI surgery, please contact the Mobile, Alabama, transvaginal mesh attorneys at Long & Long for your free case evaluation.